This post may contain affiliate links which may compensate us based on your interaction. Please read the disclosures for more information.
Pain, drug-hopping and insurance meddling are common among rheumatoid arthritis patients. Could a blood test change that? New Africa / Shutterstock.com
Editor’s Note: This story originally appeared on KFF Health News. SAN DIEGO — Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful joints hadn’t responded to Enbrel or Humira, two drugs in the same class. But the insurer insisted, so Schulte went on Remicade.
More from my site
Should You Buy a National Parks Pass in 2024?
AI Was Supposed To Replace This Job, But It’s Not Happening (Yet)
Ready to Leave the City? USDA RD Loans are Affordable Options for Home Buyers
Why DoorDash Is One of the Fastest Ways to Start a Side Hustle
10 Beach Towns With the Most Affordable Homes
4 States Where Fireworks Are Illegal Most — If Not All — of the Time
